Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-17-019680

CEO and Chairman of the Board acquired 82,810 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LAVOY THOMAS C CEO and Chairman of the Board 2017-11-20 Option exercise +82,810 $0.61 $50,100 266,333 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LAVOY THOMAS C CEO and Chairman of the Board 2017-11-20 Option exercise · Stock Options (right to buy) −82,810 632,190 D: show line 2 in the form
Loading xslF345X03/rdgdoc.xml…